Arcutis Biotherapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
ARQT on Nasdaq
Industry
Pharmaceutical Preparations
Location
3027 Townsgate Road, Suite 300, Westlake Village, California

Insiders trading volume in the past year

Arcutis Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Frazier Life Sciences VIII, L.P. 10%+ Owner $31.3M +$200K +0.64% Oct 24, 2023
Todd Franklin Watanabe Reporting Person's title: President and Chief Executive Officer, Director $9.28M -$443K -4.56% Aug 2, 2024
Bhaskar Chaudhuri Director $7.29M Jun 14, 2024
Howard G. Welgus Director $2.07M -$380K -15.5% Sep 3, 2024
Masaru Matsuda Reporting Person's title: Senior Vice President and General Counsel $1.65M -$152K -8.44% Aug 2, 2024
Patrick Burnett Reporting Person's title: Senior Vice President and Chief Medical Officer $1.61M -$911K -36.1% Aug 19, 2024
Orbimed Advisors Llc 10%+ Owner $1.47M Jun 24, 2022
Matthew Richard Moore SVP and Chief Business Officer $1.27M -$79.5K -5.88% May 1, 2024
Larry Todd Edwards SVP Chief Commercial Officer $1.26M -$68.6K -5.16% May 16, 2024
David Topper Chief Financial Officer $1.22M Apr 10, 2024
David W. Osborne Chief Technical Officer $952K Mar 6, 2023
John W. Smither Chief Financial Officer $541K Feb 13, 2024
Kenneth A. Lock Chief Commercial Officer $225K Mar 6, 2023
Patricia A. Turney SVP, Operations $223K Mar 6, 2023
Scott L. Burrows Chief Financial Officer $209K Mar 6, 2023
Keith R. Leonard Director $165K Jun 14, 2024
Sue Jean Lin Director $153K Jun 14, 2024
Terrie Curran Director $151K Jun 14, 2024
Halley E. Gilbert Director $151K Jun 14, 2024
Patrick J. Heron Director, 10%+ Owner $151K +$200K Jun 14, 2024
Neha Krishnamohan Director $126K Jun 14, 2024
Joseph L. Turner Director $15.3K Jun 1, 2022
Ricky Sun Director Jun 9, 2021

Recent Insider Transactions by Companies or Individuals for Arcutis Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.